Shimadzu is promoting advanced healthcare as solutions for research and development at every stage of healthcare, including the prevention, diagnosis, treatment, and prognosis for the purpose of overcoming cancer, dementia, and lifestyle diseases, and other disorders, and achieving a healthy life cycle.
Amyloid MS - Analysis Methods for the Early Detection of Alzheimer’s Disease via Blood Tests
- Amyloid MS is a new blood analysis method used to screen for Alzheimer’s disease. It was developed by Shimadzu and the Japanese National Center for Geriatrics and Gerontology.
- The aim of this technology is the early prediction of Alzheimer’s disease from a few drops (approximately 0.5 mL) of blood.
Related Contents
Related Literature (Shimadzu Review)
- [SHIMADZU] Shimadzu Review Vol. 77 [1・2] Development of 2019 Novel Coronavirus Detection Kit and Fully Automated Assay to Measure the Blood Concentration of a COVID-19 Therapeutic Agent -Supporting Clinical Research from Testing to Therapeutic Agent Development-
- [SHIMADZU] Shimadzu Review Vol. 76 [3・4] (2019) Medical Imaging Technologies
- [SHIMADZU] Shimadzu Review Vol. 75 [3・4] Multispectral Imaging of Fluorescent Micro Beads Using Multispectral Incoherent Holography (MIHO)
- [SHIMADZU] Shimadzu Review Vol. 75 [3・4] Development of Flow Field Flow Fractionation Device Suitable for Size Characterization of Biological Samples
- [SHIMADZU] Shimadzu Review Vol. 74 [1・2] Healthcare